Apotex Health Corp. (APTX.TO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Jeff Watson
|
President, CEO & Director | -- | -- | 1964 |
|
Mr. Brian McClelland
|
Chief Financial Officer | -- | -- | 1968 |
|
Mr. Ariel Alon
|
Chief Operating Officer | -- | -- | 1971 |
|
Mr. Francesco Tallarico
|
Chief Legal Officer & Global Head of Government Relations | -- | -- | 1983 |
|
Mr. Barry Fishman
|
Chief Corporate Development Officer | -- | -- | 1957 |
|
Ms. Carina Vassilieva C.C.P., G.R.P., M.B.A.
|
Chief Human Resources Officer | -- | -- | 1969 |
|
Dr. Kiran Krishnan Ph.D.
|
Senior Vice President of Global Regulatory Affairs | -- | -- | 1978 |
|
Mr. Martin Ares
|
President of Canada & Rest of World | -- | -- | 1967 |
|
Ms. Christine Baeder
|
President of Apotex USA & LATAM | -- | -- | 1973 |
|
Dr. Pradeep Sanghvi
|
Executive Vice President of Global Research & Development | -- | -- | 1965 |
Apotex Health Corp.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 6,000
Description
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. Apotex Health Corp. has a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. The company was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC.
Corporate Governance
Upcoming Events
November 12, 2026 at 1:30 PM UTC
Apotex Health Corp. Earnings Date
Recent Events
September 30, 2026 at 12:00 AM UTC
Dividend Date
September 15, 2026 at 12:00 AM UTC
Ex-Dividend Date
